Aurobindo Pharma hives off its biosimilars business to subsidiary CuraTeQ Biologics
Aurobindo Pharma hives off its biosimilars business to wholy-owned subsidiary ‘CuraTeQ Biologics Private Limited’ for a cash consideration of ₹361.46 crore. The... Read More